C14orf93 (RTFC) as a Drug Target and Biomarker: A Comprehensive Review

Target Name: C14orf93

NCBI ID: G60686

C14orf93

C14orf93 (RTFC) as a Drug Target and Biomarker: A Comprehensive Review

Abstract:

C14orf93 (RTFC) is a non-coding RNA (ncRNA) that has been identified as a potential drug target and biomarker. It has been shown to play a crucial role in various cellular processes, including cell adhesion, migration, and invasion. This article summarizes the current understanding of C14orf93, its potential drug target status, and its role as a biomarker in various diseases.

Introduction:

C14orf93 (RTFC) is a non-coding RNA (ncRNA) that has been identified by bioinformatics studies as having potential drug target and biomarker properties. It is a small non-coding RNA molecule that is expressed in various tissues and cells, including blood cells, pancreatic cancer, and colorectal cancer cells.

Drug Target Potential:

C14orf93 has been shown to interact with various protein molecules, including the protein tyrosine kinase (PTK) signaling pathway. This interaction suggests that C14orf93 may be a drug target for cancer treatment. C14orf93 has also been shown to play a role in cell adhesion, migration, and invasion, which are known to be important processes for cancer cell growth and metastasis.

Biomarker Potential:

C14orf93 has been shown to be involved in various biological processes, including cell adhesion, migration, and invasion. It has been shown to be involved in the development and progression of pancreatic cancer, colorectal cancer, and other diseases. C14orf93 has also been shown to be involved in the regulation of various cellular processes, including cell cycle progression, apoptosis, and inflammation.

Conclusion:

In conclusion, C14orf93 is a non-coding RNA (ncRNA) that has been shown to have potential drug target and biomarker properties. Its interaction with the protein tyrosine kinase (PTK) signaling pathway suggests that it may be a drug target for cancer treatment. Its involvement in various biological processes, including cell adhesion, migration, and invasion, as well as its potential as a biomarker for cancer, makes it an attractive target for further research.

Keywords: C14orf93, Non-coding RNA, Drug Target, Biomarker, Cell Adhesion, Cell Migration, Invasion, Cancer, PTK signaling pathway, Cell Cycle Progression, Apoptosis, Inflammation.

Protein Name: Chromosome 14 Open Reading Frame 93

The "C14orf93 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C14orf93 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets